Notably, blocking the interaction between Drp1 and ATAD3A by the peptide—DA1—was able to correct mitochondrial fragmentation and mtDNA damage, as well as attenuating HD-associated neuropathology (Zhao et al., 2019). The gene discussed is ATAD3A; the disease is Huntington disease.